Nothing Special   »   [go: up one dir, main page]

GB1181003A - Therapeutic Compositions - Google Patents

Therapeutic Compositions

Info

Publication number
GB1181003A
GB1181003A GB03049/67A GB1304967A GB1181003A GB 1181003 A GB1181003 A GB 1181003A GB 03049/67 A GB03049/67 A GB 03049/67A GB 1304967 A GB1304967 A GB 1304967A GB 1181003 A GB1181003 A GB 1181003A
Authority
GB
United Kingdom
Prior art keywords
resin
sieve
polystyrene
equililination
divinylbenzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB03049/67A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Priority to GB03049/67A priority Critical patent/GB1181003A/en
Priority to FR102712A priority patent/FR6888M/fr
Publication of GB1181003A publication Critical patent/GB1181003A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L25/00Compositions of, homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring; Compositions of derivatives of such polymers
    • C08L25/02Homopolymers or copolymers of hydrocarbons
    • C08L25/04Homopolymers or copolymers of styrene
    • C08L25/06Polystyrene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L93/00Compositions of natural resins; Compositions of derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,181,003. Medicines containing ion-exchange resins. MEAD JOHNSON & CO. 20 March, 1967, No. 13049/67. Heading A5B. [Also in Division C3] A therapeutically useful composition comprises a major amount by wt. of a non-toxic strongly basic polystyrene anion exchange resin e.g. a quaternary ammonium chloride substituted polystyrene, cross-linked with not more than 10% by wt. of divinylbenzene and a minor amount of acacia gum, the resin having a molecular weight of >3,000, water content of at least 65% by wt. after equililination with air at 100% relative humidity, the ability to absorb glycocholic acid from aq. solutions thereof, and a particle size such that at least 90% by wt. thereof passes a 200 mesh sieve (U.S. Sieve Standard). The composition may also contain a food flavour, alginic acid salt or ester.
GB03049/67A 1967-03-20 1967-03-20 Therapeutic Compositions Expired GB1181003A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB03049/67A GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions
FR102712A FR6888M (en) 1967-03-20 1967-04-14

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB03049/67A GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions
FR102712A FR6888M (en) 1967-03-20 1967-04-14

Publications (1)

Publication Number Publication Date
GB1181003A true GB1181003A (en) 1970-02-11

Family

ID=26175591

Family Applications (1)

Application Number Title Priority Date Filing Date
GB03049/67A Expired GB1181003A (en) 1967-03-20 1967-03-20 Therapeutic Compositions

Country Status (2)

Country Link
FR (1) FR6888M (en)
GB (1) GB1181003A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
WO1999011676A1 (en) * 1997-08-29 1999-03-11 Smithkline Beecham Plc Formulation
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869590D1 (en) * 1987-12-29 1992-04-30 Procter & Gamble MIXTURE FOR TREATING HYPERCHOLESTEROLEMY.
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
JPH06504281A (en) * 1990-12-20 1994-05-19 ザ、プロクター、エンド、ギャンブル、カンパニー Psyllium and cholestyramine compositions with improved palatability
WO1993018756A1 (en) * 1992-03-20 1993-09-30 The Procter & Gamble Company Anion exchange resin compositions
US5942550A (en) * 1996-01-25 1999-08-24 The Procter & Gamble Company Cholesterol lowering drink mix compositions

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252790A (en) * 1974-10-23 1981-02-24 Interx Research Corporation Method for treating gastric ulcer-prone patients
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
WO1999011676A1 (en) * 1997-08-29 1999-03-11 Smithkline Beecham Plc Formulation
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
US10688121B2 (en) 2015-08-19 2020-06-23 Alpex Pharma S.A. Granular composition for oral administration

Also Published As

Publication number Publication date
FR6888M (en) 1969-04-21

Similar Documents

Publication Publication Date Title
GB1181003A (en) Therapeutic Compositions
ES385682A1 (en) Antifoam preparations and method of preparing same
IL33856A0 (en) Alpha,alpha-disubstituted benzylimidazoles and their salts,their preparation and pharmaceutical compositions containing them
IL47937A0 (en) Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof
IL35434A (en) Basically substituted tertiary butanols,their preparation and pharmaceutical compositions containing them
IL34747A0 (en) Ergonorcornine,its 1-methyl derivative and their salts,their preparation and pharmaceutical compositions containing them
ES424192A1 (en) A procedure for the production of food granules for animals of enhanced structural integrity. (Machine-translation by Google Translate, not legally binding)
Thompson PRICE PERFORMANCE IN THIN MARKETS (FUTURES, COMMODITIES)
ES335690A1 (en) Improvement in the Granulation of Ammonium Nitrate for use as a Fertiliser and improved Granules obtained by the process
ES335190A1 (en) Improvements introduced in the preparation of compositions to stop welding. (Machine-translation by Google Translate, not legally binding)
IL35477A (en) Pharmaceutical compositions containing garcinia acid or a derivative thereof
CA974078A (en) Process for producing granular composition for use in agriculture and horticulture
IL33937A0 (en) O-chloroalkyl-and o-bromoalkyl-s-benzyl-s'-alkyl-dithiophosphoric acid esters,their preparation and their use as pesticides
CA917898A (en) Non-toxic stabilized vinyl halide resin compositions
GB1187631A (en) Improvements in Tabletting Ingredients
FR2122755A5 (en) Trichlorocyanuric acid pellets - contg boric acid for disinfecting water
CA823268A (en) Procede et composition assurant la protection temporaire d'elements metalliques
Matsuura et al. On the Calcium Enrichment of Fish (Part 2) Alkalinity in Calcium Enriched Fish, affected by Freshened Salt
Yabuki Studies on the Amino Acid Content in the Hot Salt Water Extract of Food Material On the Amino Acid Content of the Hot Salt Water Extract of Fish
GB1199039A (en) Antacid Composition
CA816385A (en) Sickle bar mower
Lowe Aphids in cereals in New Zealand
JPS535246A (en) Liquid stabilizers for polyvinyl chloride
AU450887B2 (en) Grass selective herbicide composition (additional to 416074)
Guskova Dioxidin effect of rat embryogenesis.